Aull & Monroe Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.36M Buy
18,386
+972
+6% +$114K 0.99% 31
2026
Q1
$2.09M Buy
17,414
+921
+6% +$106K 0.97% 35
2025
Q4
$1.74M Buy
16,493
+132
+0.8% +$12.4K 0.87% 40
2025
Q3
$1.37M Sell
16,361
-350
-2% -$28.8K 0.7% 49
2025
Q2
$1.32M Sell
16,711
-720
-4% -$57.2K 0.71% 46
2025
Q1
$1.56M Sell
17,431
-33
-0.2% -$3.08K 0.78% 41
2024
Q4
$1.74M Sell
17,464
-1,396
-7% -$144K 0.89% 39
2024
Q3
$2.14M Sell
18,860
-452
-2% -$53.7K 0.99% 35
2024
Q2
$2.39M Sell
19,312
-796
-4% -$103K 1.17% 30
2024
Q1
$2.65M Sell
20,108
-438
-2% -$54K 1.21% 27
2023
Q4
$2.24M Sell
20,546
-600
-3% -$62.3K 1.11% 31
2023
Q3
$2.18M Hold
21,146
1.14% 27
2023
Q2
$2.44M Hold
21,146
1.23% 28
2023
Q1
$2.25M Sell
21,146
-426
-2% -$46K 1.15% 31
2022
Q4
$2.39M Sell
21,572
-931
-4% -$95.2K 1.19% 28
2022
Q3
$1.94M Hold
22,503
1.06% 35
2022
Q2
$2.05M Hold
22,503
1.04% 35
2022
Q1
$1.85M Buy
22,503
+150
+0.7% +$11.8K 0.83% 41
2021
Q4
$1.71M Hold
22,353
0.76% 50
2021
Q3
$1.68M Sell
22,353
-212
-0.9% -$16.1K 0.83% 45
2021
Q2
$1.75M Sell
22,565
-978
-4% -$72.7K 0.83% 43
2021
Q1
$1.73M Buy
23,543
+1,825
+8% +$135K 0.84% 41
2020
Q4
$1.7M Sell
21,718
-482
-2% -$36.9K 0.9% 40
2020
Q3
$1.76M Buy
22,200
+210
+1% +$16.4K 1.03% 33
2020
Q2
$1.62M Sell
21,990
-1,643
-7% -$124K 1% 37
2020
Q1
$1.74M Hold
23,633
1.16% 28
2019
Q4
$2.05M Hold
23,633
1.04% 34
2019
Q3
$1.9M Sell
23,633
-786
-3% -$63K 1% 35
2019
Q2
$1.95M Hold
24,419
1.04% 34
2019
Q1
$1.94M Sell
24,419
-996
-4% -$74.5K 1.04% 34
2018
Q4
$1.85M Sell
25,415
-2,361
-9% -$167K 1.06% 32
2018
Q3
$1.88M Buy
27,776
+419
+2% +$26.7K 0.91% 41
2018
Q2
$1.58M Buy
27,357
+996
+4% +$56.2K 0.81% 43
2018
Q1
$1.37M Buy
26,361
+89
+0.3% +$4.81K 0.71% 48
2017
Q4
$1.41M Sell
26,272
-420
-2% -$23.3K 0.71% 48
2017
Q3
$1.63M Sell
26,692
-314
-1% -$19K 0.84% 43
2017
Q2
$1.65M Sell
27,006
-105
-0.4% -$6.39K 0.88% 39
2017
Q1
$1.64M Sell
27,111
-429
-2% -$26K 0.88% 40
2016
Q4
$1.55M Hold
27,540
0.87% 41
2016
Q3
$1.64M Sell
27,540
-189
-0.7% -$11.1K 0.94% 35
2016
Q2
$1.52M Buy
27,729
+472
+2% +$25.1K 0.88% 38
2016
Q1
$1.38M Buy
27,257
+2,096
+8% +$103K 0.83% 43
2015
Q4
$1.27M Sell
25,161
-524
-2% -$26.4K 0.79% 44
2015
Q3
$1.21M Sell
25,685
-251
-1% -$13.3K 0.78% 45
2015
Q2
$1.45M Sell
25,936
-274
-1% -$15.4K 0.85% 43
2015
Q1
$1.44M Buy
26,210
+52
+0.2% +$2.94K 0.81% 43
2014
Q4
$1.42M Sell
26,158
-2,255
-8% -$126K 0.77% 46
2014
Q3
$1.61M Buy
28,413
+642
+2% +$36K 0.85% 45
2014
Q2
$1.53M Hold
27,771
0.82% 48
2014
Q1
$1.5M Hold
27,771
0.86% 42
2013
Q4
$1.33M Buy
27,771
+1,216
+5% +$55.6K 0.77% 49
2013
Q3
$1.21M Sell
26,555
-294
-1% -$13.4K 0.78% 46
2013
Q2
$1.19M Buy
+26,849
New +$1.2M 0.8% 49

Other funds holding MRK

Aull & Monroe Investment Management's MRK Position: Q2 2026 in Review

Aull & Monroe Investment Management increased its Merck (MRK) stake by 5.6% in Q2 2026, buying an estimated $114K and bringing the position to 18,386 shares worth $2.36M. The position accounts for 0.99% of the portfolio, ranked #31.

Aull & Monroe Investment Management first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.65M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Aull & Monroe Investment Management held 18,386 shares of Merck worth $2.36M as of Q2 2026.
  • Aull & Monroe Investment Management bought 972 Merck shares in Q2 2026, an estimated $114K.
  • Merck made up 0.99% of Aull & Monroe Investment Management's portfolio in Q2 2026, its #31 holding.
  • Aull & Monroe Investment Management first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Aull & Monroe Investment Management's Merck position peaked at $2.65M in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Aull & Monroe Investment Management's 13F filing for Q2 2026, filed 20 Jul 2026.